Enter assignee name

% Expired Patents = 14.3

EPO Patents = 3

Forward Citations = 18

Loading Chart...

11 inventors (with patents filed for the assignee):

Alexander Karpeisky (6 out of 28 patents)

Shawn Patrick Zinnen (6 out of 13 patents)

Murali Urlam (1 out of 1 patent)

4. Vladimir Y Vvedensky (1 out of 1 patent)

5. Andrei P Guzaev (1 out of 34 patents)

6. Hbf Dixon (1 out of 2 patents)

7. Marat Karpeisky (1 out of 2 patents)

8. Alexander Karpeisky, Legal Representative (1 out of 1 patent)

9. Nelly Padioukova (1 out of 4 patents)

10. Sergey Mikhailov (1 out of 4 patents)

11. Grigorii Tzeitline (1 out of 4 patents)

12. H B F Dixon (2 patents)

13. Shawn Zinnen (0 patent)

7 patents: Sort by Forward Citations

1. 11324767 - Drug combination treatments using bone-targeting therapeutics for bone and bone-related disease (2022-05-10),

2. 11298366 - Ibandronate conjugates of nucleoside antimetabolites (2022-04-12),

3. 10046055 - Bone targeted therapeutics and methods of making and using the same (2018-08-14),

4. 9334300 - Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates (2016-05-10),

5. 9216204 - Bone targeted therapeutics and methods of making and using the same (2015-12-22),

6. 8586781 - Bone targeted therapeutics and methods of making and using the same (2013-11-19),

7. 7598246 - Bisphosphonate conjugates and methods of making and using the same (2009-10-06),

Mbc Pharma, Inc. is a leading pharmaceutical company that specializes in the research, development, and commercialization of innovative medicines. With a focus on improving patient outcomes and quality of life, Mbc Pharma is dedicated to advancing healthcare through cutting-edge technology and scientific expertise.

Profile summary based on public USPTO records.